Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

NCT02351752 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Primary IgA Nephropathy

Interventions

DRUG: Hydroxychloroquine Sulfate

Sponsor

LLiu